Zaremba S - Search Results

1

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.

Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Tsang KY, et al. Among authors: zaremba s. J Natl Cancer Inst. 1995 Jul 5;87(13):982-90. doi: 10.1093/jnci/87.13.982. J Natl Cancer Inst. 1995. PMID: 7629885

2

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.

Correale P, Walmsley K, Nieroda C, Zaremba S, Zhu M, Schlom J, Tsang KY. Correale P, et al. Among authors: zaremba s. J Natl Cancer Inst. 1997 Feb 19;89(4):293-300. doi: 10.1093/jnci/89.4.293. J Natl Cancer Inst. 1997. PMID: 9048833

3

Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.

Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J. Zaremba S, et al. Cancer Res. 1997 Oct 15;57(20):4570-7. Cancer Res. 1997. PMID: 9377571

4

Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.

Correale P, Walmsley K, Zaremba S, Zhu M, Schlom J, Tsang KY. Correale P, et al. Among authors: zaremba s. J Immunol. 1998 Sep 15;161(6):3186-94. J Immunol. 1998. PMID: 9743387

5

Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.

Tsang KY, Zhu M, Nieroda CA, Correale P, Zaremba S, Hamilton JM, Cole D, Lam C, Schlom J. Tsang KY, et al. Among authors: zaremba s. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2439-49. Clin Cancer Res. 1997. PMID: 9815645

6

Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide.

Salazar E, Zaremba S, Arlen PM, Tsang KY, Schlom J. Salazar E, et al. Among authors: zaremba s. Int J Cancer. 2000 Mar 15;85(6):829-38. doi: 10.1002/(sici)1097-0215(20000315)85:6<829::aid-ijc16>3.0.co;2-k. Int J Cancer. 2000. PMID: 10709104

7

Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21.

Abrams SI, Dobrzanski MJ, Wells DT, Stanziale SF, Zaremba S, Masuelli L, Kantor JA, Schlom J, Masuelle L [corrected to Masuelli L]. Abrams SI, et al. Among authors: zaremba s. Eur J Immunol. 1995 Sep;25(9):2588-97. doi: 10.1002/eji.1830250928. Eur J Immunol. 1995. PMID: 7589131

8

Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.

Abrams SI, Stanziale SF, Lunin SD, Zaremba S, Schlom J. Abrams SI, et al. Among authors: zaremba s. Eur J Immunol. 1996 Feb;26(2):435-43. doi: 10.1002/eji.1830260225. Eur J Immunol. 1996. PMID: 8617315

9

Strategies in the development of recombinant vaccines for colon cancer.

Schlom J, Tsang KY, Kantor JA, Abrams SI, Zaremba S, Greiner J, Hodge JW. Schlom J, et al. Among authors: zaremba s. Semin Oncol. 1999 Dec;26(6):672-82. Semin Oncol. 1999. PMID: 10606260 Review.

10

Cancer vaccine development.

Schlom J, Tsang KY, Kantor JA, Abrams SI, Zaremba S, Greiner J, Hodge JW. Schlom J, et al. Among authors: zaremba s. Expert Opin Investig Drugs. 1998 Sep;7(9):1439-52. doi: 10.1517/13543784.7.9.1439. Expert Opin Investig Drugs. 1998. PMID: 15992042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters